ResearcherErasmus MCActive in the last 2 years
Mauro Loi
Matched on ORCID iD 0000-0002-0360-3275; OpenAlex author ID A5089266911. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: "Pancreat… Co-author DOI 10.1016/j.annonc.2024.05.003↗
- Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy? Last author DOI 10.1016/j.canrad.2022.06.020↗
- A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome. First author DOI 10.1016/j.radonc.2020.11.006↗
- Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. Co-author DOI 10.1016/j.radonc.2019.01.020↗
- Modeling daily changes in organ-at-risk anatomy in a cohort of pancreatic cancer patients. First author DOI 10.1016/j.radonc.2019.01.030↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joost J.M.E. Nuyttens · 4 shared papers, 2019–2024 · strength 0.57
- Paper Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. L… DOI 10.1016/j.annonc.2024.05.003↗
- Paper A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): L… DOI 10.1016/j.radonc.2020.11.006↗
- Paper Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. DOI 10.1016/j.radonc.2019.01.020↗
- F. Huguet · 2 shared papers, 2022–2024 · strength 0.36
- Paper Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. L… DOI 10.1016/j.annonc.2024.05.003↗
- Paper Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy? DOI 10.1016/j.canrad.2022.06.020↗
- Mustafa Suker · 2 shared papers, 2019–2021 · strength 0.26
- Paper A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): L… DOI 10.1016/j.radonc.2020.11.006↗
- Paper Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. DOI 10.1016/j.radonc.2019.01.020↗
- Casper H.J. van Eijck · 2 shared papers, 2019–2021 · strength 0.26
- Paper A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): L… DOI 10.1016/j.radonc.2020.11.006↗
- Paper Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. DOI 10.1016/j.radonc.2019.01.020↗
- Mischa S. Hoogeman · 2 shared papers, 2019 · strength 0.21
- Alba Magallon-Baro · 2 shared papers, 2019 · strength 0.21
- V. Vendrely · 1 shared paper, 2024 · strength 0.20
- M. Hawkins · 1 shared paper, 2024 · strength 0.20
- Anna M E Bruynzeel · 1 shared paper, 2024 · strength 0.20
- Marta Scorsetti · 1 shared paper, 2024 · strength 0.20
- Christelle Bouchart · 1 shared paper, 2024 · strength 0.20
- Eva Versteijne · 1 shared paper, 2024 · strength 0.20
- Maria Ausilia Teriaca · 1 shared paper, 2021 · strength 0.16
- Ferry A.L.M. Eskens · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.